Cardinal Health Q1 revenue rises 5%, EPS up 27%, raises FY27 EPS guidance to $12.80-$13.00

Cardinal Health reported a 5% revenue increase to $67.5 billion in Q1 FY2027, with GAAP diluted EPS rising 27% to $2.38. Non-GAAP operating earnings grew 17% to $1 billion, and non-GAAP diluted EPS increased 28% to $3.26. The company completed a $500 million share repurchase and raised its FY2027 non-GAAP EPS guidance to $12.80-$13.00, reflecting strong performance and strategic investments. Cardinal Health also highlighted growth in its Pharmaceutical and Specialty Solutions segment and plans to acquire AdaptHealth's Diabetes Health business.

Cardinal Health's stock price on Pluang stands at USD 269.00 as of November 5, 2026, 19:04 WIB, showing a 2.70% increase in one day. This price level contrasts with its market cap of $60.65 billion, highlighting significant investor interest reflected in a 100% buy order activity on the platform. The stock's dividend yield is relatively modest at 0.79%, with an average hold time of 70 days, indicating a balanced approach between income and growth for Pluang investors.